Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (31)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Navarro, F.
Right arrow Articles by Mirelis, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Navarro, F.
Right arrow Articles by Mirelis, B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (2001) 48, 383-389
© 2001 The British Society for Antimicrobial Chemotherapy

CMY-2-producing Salmonella enterica, Klebsiella pneumoniae, Klebsiella oxytoca, Proteus mirabilis and Escherichia coli strains isolated in Spain (October 1999–December 2000)

Ferran Navarroa, Emilio Perez-Trallerob,*, José M. Marimonb, Roxana Aliagaa, Maria Gomarizb and Beatriz Mirelisa

a Microbiology Department, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma 08025 Barcelona; b Microbiology Department, Complejo Hospitalario Donostia, Universidad del País Vasco, Avenida Dr. Beguiristain s/n, 20014 San Sebastián, Spain

CMY-2 plasmid-mediated AmpC ß-lactamase (CMY-2) was detected in 21 isolates from two hospitals located in different geographical regions of Spain between October 1999 and December 2000. The isolates comprised two Salmonella enterica serovars (Mikawasima and Montevideo), 16 Escherichia coli, one Klebsiella pneumoniae, one Klebsiella oxytoca and one Proteus mirabilis. In addition to the expected resistance to ß-lactams, including extended-spectrum cephalosporins and cefoxitin, all isolates showed a broad spectrum of associated resistance. All were resistant to sulfamethoxazole, chloramphenicol, tetracycline and streptomycin, and all but two were also resistant to gentamicin. Five isolates were studied in detail and all transferred CMY-2 and other resistance determinants by conjugation. Genomic DNA restriction pattern analysis of the E. coli isolates excluded the dissemination of a single clone. To the best of our knowledge this is the first time that CMY-2 has been detected in P. mirabilis, K. oxytoca and S. enterica serovars Mikawasima and Montevideo. It is also the first time that CMY-2 has been described in Spain.

* Corresponding author. Tel: +34-943-00-70-46; Fax: +34-943-00-70-63; E-mail: labmikro{at}terra.es


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J Antimicrob ChemotherHome page
S. Lavilla, J. J. Gonzalez-Lopez, E. Miro, A. Dominguez, M. Llagostera, R. M. Bartolome, B. Mirelis, F. Navarro, and G. Prats
Dissemination of extended-spectrum {beta}-lactamase-producing bacteria: the food-borne outbreak lesson
J. Antimicrob. Chemother., June 1, 2008; 61(6): 1244 - 1251.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
L. M. Aragon, B. Mirelis, E. Miro, C. Mata, L. Gomez, A. Rivera, P. Coll, and F. Navarro
Increase in {beta}-lactam-resistant Proteus mirabilis strains due to CTX-M- and CMY-type as well as new VEB- and inhibitor-resistant TEM-type {beta}-lactamases
J. Antimicrob. Chemother., May 1, 2008; 61(5): 1029 - 1032.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
Y. Li, Q. Li, Y. Du, X. Jiang, J. Tang, J. Wang, G. Li, and Y. Jiang
Prevalence of Plasmid-Mediated AmpC {beta}-Lactamases in a Chinese University Hospital from 2003 to 2005: First Report of CMY-2-Type AmpC {beta}-Lactamase Resistance in China
J. Clin. Microbiol., April 1, 2008; 46(4): 1317 - 1321.
[Abstract] [Full Text] [PDF]


Home page
J Med MicrobiolHome page
H. E. Sidjabat, K. M. Townsend, M. Lorentzen, K. S. Gobius, N. Fegan, J. J.-C. Chin, K. A. Bettelheim, N. D. Hanson, J. C. Bensink, and D. J. Trott
Emergence and spread of two distinct clonal groups of multidrug-resistant Escherichia coli in a veterinary teaching hospital in Australia.
J. Med. Microbiol., August 1, 2006; 55(Pt 8): 1125 - 1134.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
M. M. D'Andrea, E. Nucleo, F. Luzzaro, T. Giani, R. Migliavacca, F. Vailati, V. Kroumova, L. Pagani, and G. M. Rossolini
CMY-16, a Novel Acquired AmpC-Type {beta}-Lactamase of the CMY/LAT Lineage in Multifocal Monophyletic Isolates of Proteus mirabilis from Northern Italy
Antimicrob. Agents Chemother., February 1, 2006; 50(2): 618 - 624.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
M. Batchelor, K. L. Hopkins, E. J. Threlfall, F. A. Clifton-Hadley, A. D. Stallwood, R. H. Davies, and E. Liebana
Characterization of AmpC-Mediated Resistance in Clinical Salmonella Isolates Recovered from Humans during the Period 1992 to 2003 in England and Wales
J. Clin. Microbiol., May 1, 2005; 43(5): 2261 - 2265.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
E. Miro, B. Mirelis, F. Navarro, L. Matas, M. Gimenez, and C. Rabaza
Escherichia coli Producing an ACC-1 Class C {beta}-Lactamase Isolated in Barcelona, Spain
Antimicrob. Agents Chemother., February 1, 2005; 49(2): 866 - 867.
[Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
T. Kruger, D. Szabo, K. H. Keddy, K. Deeley, J. W. Marsh, A. M. Hujer, R. A. Bonomo, and D. L. Paterson
Infections with Nontyphoidal Salmonella Species Producing TEM-63 or a Novel TEM Enzyme, TEM-131, in South Africa
Antimicrob. Agents Chemother., November 1, 2004; 48(11): 4263 - 4270.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
M. Edelstein, M. Pimkin, T. Dmitrachenko, V. Semenov, N. Kozlova, D. Gladin, A. Baraniak, and L. Stratchounski
Multiple Outbreaks of Nosocomial Salmonellosis in Russia and Belarus Caused by a Single Clone of Salmonella enterica Serovar Typhimurium Producing an Extended-Spectrum {beta}-Lactamase
Antimicrob. Agents Chemother., August 1, 2004; 48(8): 2808 - 2815.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
A. Makanera, G. Arlet, V. Gautier, and M. Manai
Molecular Epidemiology and Characterization of Plasmid-Encoded {beta}-Lactamases Produced by Tunisian Clinical Isolates of Salmonella enterica Serotype Mbandaka Resistant to Broad-Spectrum Cephalosporins
J. Clin. Microbiol., July 1, 2003; 41(7): 2940 - 2945.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
L. Armand-Lefevre, V. Leflon-Guibout, J. Bredin, F. Barguellil, A. Amor, J. M. Pages, and M.-H. Nicolas-Chanoine
Imipenem Resistance in Salmonella enterica Serovar Wien Related to Porin Loss and CMY-4 {beta}-Lactamase Production
Antimicrob. Agents Chemother., March 1, 2003; 47(3): 1165 - 1168.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
E. Miro, F. Navarro, B. Mirelis, M. Sabate, A. Rivera, P. Coll, and G. Prats
Prevalence of Clinical Isolates of Escherichia coli Producing Inhibitor-Resistant {beta}-Lactamases at a University Hospital in Barcelona, Spain, over a 3-Year Period
Antimicrob. Agents Chemother., December 1, 2002; 46(12): 3991 - 3994.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
S. Sanchez, M. A. McCrackin Stevenson, C. R. Hudson, M. Maier, T. Buffington, Q. Dam, and J. J. Maurer
Characterization of Multidrug-Resistant Escherichia coli Isolates Associated with Nosocomial Infections in Dogs
J. Clin. Microbiol., October 1, 2002; 40(10): 3586 - 3595.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.